Xeris Pharmaceuticals Inc (NQ: XERS )
2.570
+0.090
(+3.63%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 16, 2024
Add to My Watchlist
All News about Xeris Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240708688946/en/2178838/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
Xeris Biopharma Announces CEO Succession Plan
July 08, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240703480900/en/2175482/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240603311134/en/2147784/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Xeris Biopharma Holdings
March 05, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20240530612890/en/2145175/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240530275222/en/2143504/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/13/Image32.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240509287355/en/2125539/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/06/stock-chart-1863880-1920-60_0.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240506079856/en/2119832/5/Beta_Bionics_Logo_-_2Color.jpg)
![](https://mms.businesswire.com/media/20240502061352/en/2110350/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240403328919/en/2086848/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240402611352/en/2085318/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240306129214/en/2055782/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://mms.businesswire.com/media/20240306343645/en/2055767/22/xeris_BIOPHARMA_TM_L_CMYK_002.jpg)
![](https://mms.businesswire.com/media/20240228184972/en/2046125/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20240205852546/en/2021290/22/xeris_BIOPHARMA_TM_L.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/10/image_4.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/09/chwy1600c_chewy.jpg)
![](https://investorplace.com/wp-content/uploads/2019/11/amgn-stock-1.jpg)
![](https://mms.businesswire.com/media/20240109335095/en/1994963/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/small-cap-stock-winner.jpg)
![](https://mms.businesswire.com/media/20240105200069/en/1988826/22/xeris_BIOPHARMA_TM_L_CMYK_%28002%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/04/lamb_weston_-_logo.jpg?width=1200&height=800&fit=crop)
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://mms.businesswire.com/media/20240104585894/en/1987301/22/xeris_BIOPHARMA_TM_L_CMYK.jpg)
Xeris Biopharma Updates Its Outlook for 2023
January 04, 2024
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.